Osteopenia News and Research

RSS

Osteopenia is a condition where bone mineral density is lower than normal. It is considered by many doctors to be a precursor to osteoporosis. However, not every person diagnosed with osteopenia will develop osteoporosis. More specifically, osteopenia is defined as a bone mineral density T-score between -1.0 and -2.5.

Men who survive childhood leukemia have lower bone mineral density

Men who survived childhood leukemia treatment into adulthood were more likely to have low bone mineral density than other adults their age, putting them at risk of osteoporosis and bone fractures, according to a new study.

3 Dec 2008

Study identifies causes of bone loss in breast cancer survivors

Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss.

19 Nov 2008

Knowing means simplifying: gluten-free diet alone is enough to cure the bones of pediatric patients with celiac disease

Individuals affected by celiac disease (gluten intolerance) often present an altered calcium (Ca2+) metabolism that can cause osteopenia, a bone mass decrease due to the impaired adsorption of this mineral, which can lead to osteoporosis (in 35-85% of the cases).

27 Jul 2008

Can long-term use of Fosomax hinder bone healing?

There is new evidence linking risk for one kind of fracture with long-term use of bisphosphonates -- drugs like Fosamax that are prescribed to treat osteoporosis in older persons by increasing bone density in order to prevent fractures.

26 Jun 2008

First study to examine vitamin D insufficiency in pediatric patients with low bone density

Vitamin D insufficiency is common in adults and is emerging in the world of pediatrics. A mild degree of vitamin D deficiency, also known as vitamin D insufficiency, causes rickets in children and can be treated with increased amount of nutritional vitamin D intake as well as increased sun exposure.

2 Jun 2008

Avoiding spleen removal for Cooley's anemia sufferers

Researchers from Weill Cornell Medical College may have discovered the precise role of a gene in one of the world's most common blood disorders, beta-thalassemia, commonly known as Cooley's anemia. Along with sickle-cell anemia, Cooley's anemia is the most commonly inherited disease in the world, affecting many people of Mediterranean descent, and 20 out of every 100,000 African-Americans. The World Health Organization estimates that between 50,000-100,000 children are born with the disease each year.

27 May 2008

Menstrual status and long-term cardiovascular effects of intense exercise in top elite athlete women’

It has long been assumed that menstrual disorders amongst elite female athletes are related to tough training regimes combined with insufficient energy intake. However, a new doctoral thesis from the Swedish medical university Karolinska Institutet overturns old ideas that elite sport can damage the health. Many elite female athletes can have a congenital condition, that gives them higher levels of testosterone and that might even contribute to their sporting successes.

17 Apr 2008

Value of drugs for pre-osteoporosis exaggerated

A series of recent scientific publications have exaggerated the benefits and underplayed the harms of drugs to treat pre-osteoporosis or "osteopenia" potentially encouraging treatment in millions of low risk women, warn experts in this week's BMJ.

21 Jan 2008

Causes of male infertility

Two reports from physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center shed new light on male infertility.

18 Oct 2007

Exercise, osteopenia and men

According to the National Osteoporosis Foundation, osteoporosis affects more than 2 million men in the United States and nearly 12 million more have osteopenia - clinically significant low bone density that is less severe than osteoporosis.

17 Oct 2007

Nutritional deficiencies after gastric bypass surgery

Two studies by a group of researchers at Washington Hospital Center highlight potential postoperative nutritional deficiencies among patients who undergo gastric bypass surgery to treat obesity.

16 Oct 2007

Gastric bypass surgery may cause post-op nutrient deficiencies

Two studies by a group of researchers at Washington Hospital Center highlight potential postoperative nutritional deficiencies among patients who undergo gastric bypass surgery to treat obesity.

16 Oct 2007

Prevention and treatment of vitamin D deficiency

Boston, MA:In a review article to appear in the July 19th issue of the New England Journal of Medicine, Dr. Michael Holick, an internationally recognized expert in vitamin D, provides an overview of his pioneering work that expounds on the important role vitamin D plays in a wide variety of chronic health conditions, as well as suggesting strategies for the prevention and treatment of vitamin D deficiency.

19 Jul 2007

Bisphosphonates for osteoporosis treatment in women

A class of drugs called bisphosphonates has become the new mainstay treatment for postmenopausal women diagnosed with osteoporosis in the post-hormone-replacement era.

10 May 2007

Osteopenia and cancer in children and adolescents

Physicians caring for children with cancer should be on the lookout for signs of bone fragility caused by disease and treatment, according to a new report.

26 Feb 2007

Osteonecrosis of the jawbone and oral bisphosphonates

People taking oral bisphosphonates, a type of drug used to treat osteoporosis, osteopenia and Paget's disease of bone, should be aware of potential risks when undergoing certain dental procedures, according to guidelines published in this month's Journal of the American Dental Association (ADA).

4 Aug 2006

Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy

The patient of a periodontist in private practice in New Orleans developed osteonecrosis of the jaw (ONJ), a condition that can cause severe, often irreversible and debilitating damage to the jaw, following periodontal surgical therapy.

11 Apr 2006

Loyola to study for first time IV medication for osteopenia and inflammatory bowel diseases

Researchers at the Osteoporosis and Metabolic Bone Disease Center and the Division of Gastroenterology at Loyola University Health System are studying a once-yearly, 15-minute infusion of an intravenous (IV) medication in patients with osteopenia (low bone mass) and inflammatory bowel diseases (IBD) that, if proven effective, may be considered the standard of treatment.

10 Jan 2006

Loyola researchers hope that zoledronic acid will be effective and safe for patients with inflammatory bowel diseases (IBD)

26 Jul 2005

Alendronate combined with calcium and vitamin D almost completely prevented further bone loss in the first 4 months afte liver transplant

A new study found that the drug used to treat osteoporosis, when used in combination with calcium and vitamin D, can prevent the additional bone loss that commonly occurs after liver transplants. The treatment also helped stabilize bone loss in patients who already had osteoporosis, and helped improve their bone mineral density (BMD).

20 Jul 2005